MEDIF
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q1 | -0.00 | $9M | -$781,012 |
| 2025 Q4 | -0.00 | $11M | $474,612 |
| 2025 Q3 | -0.01 | $11M | -$174,000 |
| 2025 Q2 | -0.01 | $12M | -$3M |
| 2025 Q1 | -0.00 | $11M | -$3M |
| 2024 Q4 | -0.00 | $12M | -$1M |
| 2024 Q3 | -0.01 | $10M | -$695,000 |
| 2024 Q2 | -0.01 | $10M | -$2M |